These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2524680)

  • 1. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide.
    Raine AE; Bock A; Muller FB; Erne P; Bolli P; Brunner F; Buhler FR
    Nephrol Dial Transplant; 1989; 4(3):222-7. PubMed ID: 2524680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN; Vaziri ND; Pandian MR; Kaupke J
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis.
    Wilkins MR; Wood JA; Adu D; Lote CJ; Kendall MJ; Michael J
    Clin Sci (Lond); 1986 Aug; 71(2):157-60. PubMed ID: 2941209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients.
    Corboy JC; Walker RJ; Simmonds MB; Wilkins GT; Richards AM; Espiner EA
    Clin Sci (Lond); 1994 Dec; 87(6):679-84. PubMed ID: 7874859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure.
    Lang CC; Choy AM; Henderson IS; Coutie WJ; Struthers AD
    Clin Sci (Lond); 1992 Feb; 82(2):127-31. PubMed ID: 1311649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
    Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
    Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.
    Anderson JV; Raine AE; Proudler A; Bloom SR
    J Endocrinol; 1986 Aug; 110(2):193-6. PubMed ID: 2943848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis.
    Plum J; Grabensee B
    J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide plasma levels during hemodialysis and hemofiltration in patients with end-stage renal disease.
    Groll J; Hagemann J; Röhrich B; Schaefer K
    Int J Artif Organs; 1989 May; 12(5):284-8. PubMed ID: 2525530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atrial natriuretic peptide (99-126) in chronic renal disease in man.
    Swainson CP; Craig KC
    Nephrol Dial Transplant; 1991; 6(5):336-41. PubMed ID: 1831249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis.
    Horký K; Srámková J; Tesar V; Lachmanová J; Widimský J
    Physiol Bohemoslov; 1988; 37(4):299-305. PubMed ID: 2973615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
    de Châtel R; Makó J; Tóth M; Barna I; Lang RE
    Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients.
    Leunissen KM; Menheere PP; Cheriex EC; van den Berg BW; Noordzij TC; van Hooff JP
    Nephrol Dial Transplant; 1989; 4(5):382-6. PubMed ID: 2528086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohumoral responses to a single haemodialysis in chronic renal patients.
    Uusimaa P; Huttunen K; Ruskoaho H; Linnaluoto M; Ikäheimo M
    Acta Physiol Scand; 1999 Jan; 165(1):25-31. PubMed ID: 10072093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure.
    Rascher W; Tulassay T; Lang RE
    Lancet; 1985 Aug; 2(8450):303-5. PubMed ID: 2862469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
    Selçuk Y; San A; Bakan E; Yiğitoğlu R
    Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP; Feifel K; Mayer-Wehrstein R
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide in renal transplantation.
    Plum J; Scholtz W; Grabensee B
    Horm Res; 1996; 46(2):74-82. PubMed ID: 8871185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide release and volume regulation following kidney transplantation.
    Zuber M; Kiowski W; Huser B; Erne P; Bühler FR; Thiel G
    Clin Nephrol; 1993 Aug; 40(2):91-5. PubMed ID: 8222378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of atrial natriuretic factor in chronic renal failure.
    Tonolo G; Soro A; Scardaccio V; Troffa C; Pazzola A; Manunta P; Melis MG; Pala F; Madeddu P; Rovasio PP
    J Hypertens Suppl; 1989 Dec; 7(6):S238-9. PubMed ID: 2534409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.